Benkert, T. F., Dietz, L., Hartmann, E. M., Leich, E., Rosenwald, A., Serfling, E., . . . Berberich-Siebelt, F. (2012). Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis. Public Library of Science.

Benkert, Thomas F., Lena Dietz, Elena M. Hartmann, Ellen Leich, Andreas Rosenwald, Edgar Serfling, Mathias Buttmann, et Friederike Berberich-Siebelt. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients With Multiple Sclerosis. Public Library of Science, 2012.

Benkert, Thomas F., et al. Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients With Multiple Sclerosis. Public Library of Science, 2012.